Answers are grounded in this paper and cite their sources.
Background: Reduced fetal movements are associated with adverse perinatal outcomes and commonly prompt unscheduled care. We explored clinicians’ views on self-monitoring of fetal movements, and the potential role of a fetal movement monitoring device in clinical practice. Methods: An anonymous online survey was distributed in Ireland and the UK. Quantitative and qualitative responses were collected on current advice for reduced fetal movements, perceived anxiety in patient groups, views on potential risks/benefits of fetal movement monitoring devices, desired device characteristics, and preferences regarding data access and responsibility. Descriptive statistics and content analysis were performed. Results: 101 clinicians responded; 44/82 (53.7%) were obstetrician-gynaecologists and 38/82 (46.3%) were midwives. The majority of participants advised hospital attendance in the event of FM-related concern, and to take note of their baby’s pattern of movements. 61/82 (74%) of clinicians reported that they frequently encountered anxiety relating to fetal movements in their patients. Anticipated benefits of a home FM monitor included reassurance (31/53, 58%) and fewer hospital admissions (12/53, 23%). Key concerns were a potential for increased patient anxiety (20/52, 38%), inaccurate information (25/52, 48%) and over-reliance on a device (15/52, 29%). Accuracy/reliability (31/50; 62%), ease of use (13/50; 26%) and durability (10/50; 20%) were rated as the most important device attributes. Most clinicians wished to be able to view device data, though a minority did not want to have the responsibility for monitoring. Overall, 36/53, 68% of responders would consider using a fetal movement monitor in their practice. Conclusions: The respondees perceived potential value for home FM monitors as an adjunct to current care but highlighted potential risks related to patient anxiety, data accuracy and professional responsibility. Evidence of clinical efficacy and safety, alongside patient-experience surveys and data governance, would be required for the introduction of a clinically-indicated home fetal movement monitoring device.
No takes yet. Share an insight, caveat, or question.
Waterstone et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: